Accolade to Announce Fiscal Third Quarter 2025 Financial Results

ACCD 12.16.2024

SERA-AI Powered Highlights
Date of Upcoming Event:2024-01-09
Name of Upcoming Event:Conference Call for Fiscal Q3 Results
Full Press ReleaseSEC FilingsOur ACCD Tweets

About Gravity Analytica

Recent News

    Recent Filings

    • 01.22.2025 - 4 Statement of changes in beneficial ownership of securities
    • 01.21.2025 - SCHEDULE 13D General Statement of Acquisition of Beneficial Ownership
    • 01.21.2025 - DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material
    PDF Version

    SEATTLE, Dec. 16, 2024 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD) today announced that it will release fiscal third quarter 2025 financial results on Thursday, January 9, 2024 after the market closes. In conjunction, the company will host a conference call to review results at 4:30 p.m. E.T. on the same day.

    Conference Call Details

    To Listen via Telephone: Pre-registration is required by the conference call operator. Please pre-register by clickinghere. (https://register.vevent.com/register/BI0dce2f02ed2f44c8901127623aa788c3) Upon registering, you will be emailed a dial-in number, direct passcode and unique PIN.

    To Listen via Internet: The conference call can be accessed via a live audio webcast that will be available online athttp://ir.accolade.com.

    Replay: A replay of the call will be available for one year via webcast for on-demand listening shortly after the completion of the call, athttp://ir.accolade.com.

    About Accolade, Inc.

    Accolade (Nasdaq: ACCD) is a Personalized Healthcare company that provides millions of people and their families with exceptional healthcare experiences so they can live their healthiest lives. Accolade’s employer, health plan, and consumer solutions combine virtual primary care and mental health, expert medical opinion, and best-in-class care navigation. These offerings are built on a platform that is engineered to care through predictive engagement of population health needs, proactive care that improves outcomes and cost savings, and by addressing barriers to access and continuity of care. Accolade consistently receives consumer satisfaction ratings of over 90%. For more information, visitaccolade.com. Follow us onLinkedIn,Twitter,InstagramandFacebook.

    Investor Contact:

    Todd Friedman, Investor Relations,IR@accolade.com

    Media Contact:

    Media Inquiries,Media@accolade.com

    Source: Accolade

    This press release was published by a CLEAR® Verified individual.

    Please be aware that the following content has been generated by an AI system and may contain errors, inconsistencies, or outdated information. It is provided as-is without any warranties or guarantees of accuracy. We strongly recommend using this content as a starting point for further research and consultation with relevant experts or authorities. We disclaim any liability for damages or losses resulting from the use or reliance on this content.Please note that this is a beta version of the Gravity Analytica LLC’s AI Service which isstill undergoing final testing before its official release. Theplatform, its software and all content found on it are provided on an“as is” and “as available” basis. Gravity Analytica LLC does not give any warranties,whether express or implied, as to the suitability or usability of thisservice, webpage, or its software or any of its content.Should you encounter any bugs, glitches, lack of functionality orother problems on the website, please let us know immediately so wecan rectify these accordingly. Your help in this regard is greatlyappreciated! You can write to us at this addressteam@gravityanalytica.com